Paris Panayiotopoulos

Sharp rise in leukemia drug price draws lawmaker scrutiny

ARIAD Pharmaceuticals' decision to raise the price of its leukemia drug to nearly $200,000 a year has drawn the attention of some of the most prominent members of Congress.

Ron Shinkman Oct 23, 2016 6:30pm